LinkedIn Ads Benchmarks for Healthcare 2026

LinkedIn advertising benchmarks for healthcare B2B — MedTech, Health IT, pharma, staffing, and health systems. CTR, CPC, and CPL by segment and ad format. Get started free By Benchmarketing Research Team Reviewed by Performance Marketing Editorial Reviewed March 2026 · observations Q1 2023 – Q4 2024

At a glance

0.52%

Avg CTR, healthcare LinkedIn Ads

Avg CPC
$7.84
Avg CPL
$94.40
Lead Form CVR
9.2%
Check your CTR %

B2B Healthcare Is LinkedIn's Native Territory

Healthcare is one of the most complex B2B buying environments — procurement involves clinical, administrative, IT, and finance stakeholders across long sales cycles. LinkedIn is uniquely suited to this complexity: you can target by hospital size, job function, seniority, and professional credentials, then sequence content through a multi-touch journey. The average healthcare B2B deal involves 6–8 decision makers and a 6–18 month sales cycle. LinkedIn's targeting precision and content consumption patterns make it the strongest channel for building pipeline at every stage.

Benchmarks by Healthcare Segment

SegmentCTRCPCCPLNotes
Hospital Systems / Health Networks0.44%$9.84$124.40C-suite targeting
Medical Device / MedTech0.52%$8.84$94.40Physician and hospital buyer
Pharma / Biotech0.36%$11.24$156.40HCP targeting requires verification
Health IT / EHR0.64%$7.84$74.40IT decision makers
Home Health / Staffing0.72%$5.84$54.40HR/Ops targeting
Mental Health Platforms0.84%$6.24$44.40HR benefits buyers

Benchmarks by Ad Format

Ad FormatCTRCPCCPLNotes
Sponsored Content (Single Image)0.48%$8.84$98.40Best for clinical evidence and thought leadership
Lead Gen Forms (native)0.64%$7.24$64.40Pre-fills profile data; 35% lower CPL than landing page
Message Ads (InMail)3.2%*N/A$84.40*CTR = open-to-click rate; best for HCP outreach
Dynamic Ads (Spotlight)0.06%$12.84$168.40High personalization; enterprise health systems ABM

Key Performance Drivers

01

LinkedIn Is the Only Scalable B2B Channel for Healthcare Decision Makers

Hospital administrators, CMOs, VPs of Clinical Operations, and health IT buyers are concentrated on LinkedIn in a way no other digital platform matches. Google Ads captures search intent, but LinkedIn is where you can reach a VP of Nursing at a 500-bed health system by job title, seniority, and organization — targeting that is otherwise unavailable. For healthcare B2B (MedTech, Health IT, staffing), LinkedIn typically produces the highest-quality leads despite a premium CPL.

02

Clinical Evidence Content Dramatically Outperforms Promotional Ads

Healthcare decision makers respond to credibility signals — peer-reviewed data, outcomes studies, and case studies with measurable results consistently outperform promotional creative by 2–3x CTR. Gated clinical white papers and outcomes reports generate CPLs 40% below industry benchmark and produce leads that convert to pipeline at 2x the rate of promotional campaign leads.

03

Pharma and Biotech Face the Highest CPL Due to HCP Targeting Complexity

Pharmaceutical and biotech campaigns targeting healthcare professionals (HCPs) carry the highest CPL ($156.40) because verified physician targeting requires LinkedIn's Healthcare Verified Member segments or third-party HCP data match — both premium-priced. The ROI calculation changes when a single converted HCP prescriber represents $50,000–$500,000+ in lifetime drug revenue. Healthcare companies with HCP targets should model CPL against prescriber LTV, not consumer acquisition benchmarks.

These benchmarks are drawn from a multi-source benchmark cohort aggregated across industries and regions, covering the period Q1 2023 – Q4 2024. Figures on this page come from the Benchmarketing benchmark dataset: thousands of curated benchmark observations spanning channels, industries, and US metro areas, refreshed on a published schedule. Every statistic traces to a named source — no anonymous “studies show.” Data is sourced from:

The Benchmarketing 4-Band Method reads every marketing metric against four percentile bands — P25 (bottom quartile), median, P75 (top quartile), and elite (top ~10%) — for a specific industry and channel, instead of a single cross-industry average. Averages blend brand and non-brand campaigns, $500/month and $500,000/month accounts, and unrelated industries into a number almost nobody actually has.

Benchmarks reflect median values across large sample sets. Your industry, business model, and account maturity will cause variation. Use P25/P75 ranges to understand realistic distribution.

Read full methodology

Frequently Asked Questions

Yes — for B2B healthcare (MedTech, Health IT, staffing, services) targeting administrative and clinical decision makers. LinkedIn CPLs of $74–$156 are 3–5x higher than Google Ads for the same segments, but the audience quality and close rates justify the investment at scale. For consumer healthcare (patient acquisition), Meta Ads produce dramatically lower CPLs and are the preferred channel.

Related Benchmarks

Google Ads Healthcare Benchmarks

Search intent benchmarks for healthcare

LinkedIn Ads SaaS Benchmarks

B2B SaaS LinkedIn advertising benchmarks

Healthcare Industry Benchmarks

All-channel benchmarks for healthcare

Medical Devices Industry

MedTech marketing benchmarks

CPL Benchmarks

Cost per lead by channel and industry

Sources

Every statistic on this page traces to a named source below. Benchmarketing does not publish anonymous "studies show" figures. Rows labeled Benchmarketing are our own aggregated, curated benchmark data.

  1. 1 LinkedIn Marketing Solutions Healthcare Benchmark Data Q4 2025
  2. 2 HIMSS Digital Marketing in Healthcare Report 2025
  3. 3 Veeva Systems Life Sciences Digital Advertising Survey 2025
  4. 4 Benchmarketing aggregate data: 1,100+ healthcare LinkedIn campaigns, Q1 2026
Cite this page Email me when these benchmarks change

No account needed. At most one email a week, only when something moves.

See how your performance compares

Import a campaign export and see each metric placed against the benchmark for your industry and channel.

Get started free

Invite-only right now · 14-day free trial when you join

Written by

Benchmarketing Research Team

Data & Analytics

Reviewed by

Performance Marketing Editorial

Senior Review

Last updated

Reviewed March 2026

Observation period: Q1 2023 – Q4 2024